EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina

Sofia Papadogkonaki, Dimitris Spyridakos iD, Emmanouela Lapokonstantaki, Nikos Chaniotakis iD, Alexandros Makriyannis, Michael S Malamas, Kyriaki Thermos

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sofia Papadogkonaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece. Hauptthemen laut MEDLINE: Endocannabinoids, Microglia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Hellenic Foundation for Research and Innovation/General Secretariat for Research and Technology, Special Account for Research, University of Crete.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endocannabinoid system (ECS) is a new target for the development of retinal disease therapeutics, whose pathophysiology involves neurodegeneration and neuroinflammation. The endocannabinoid 2-arachidonoylglycerol (2-AG) affects neurons and microglia by activating CB1/CB2 cannabinoid receptors (Rs). The aim of this study was to investigate the effects of 2-AG on the CB1R expression/downregulation and retinal neurons/reactive microglia, when administered repeatedly (4 d), in three different paradigms. These involved the 2-AG exogenous administration (a) intraperitoneally (i.p.) and (b) topically and (c) by enhancing the 2-AG endogenous levels via the inhibition (AM11920, i.p.) of its metabolic enzymes (MAGL/ABHD6). Sprague Dawley rats were treated as mentioned above in the presence or absence of CB1/CB2R antagonists and the excitatory amino acid, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). Immunohistochemistry, Western blot and a 2-AG level analyses were performed. The 2-AG repeated treatment (i.p.) induced the CB1R downregulation, abolishing its neuroprotective actions. However, 2-AG attenuated the AMPA-induced activation of microglia via the CB2R, as concurred by the AM630 antagonist effect. Topically administered 2-AG was efficacious as a neuroprotectant/antiapoptotic and anti-inflammatory agent. AM11920 increased the 2-AG levels providing neuroprotection against excitotoxicity and reduced microglial activation without affecting the CB1R expression. Our findings show that 2-AG, in the three paradigms studied, displays differential pharmacological profiles in terms of the downregulation of the CB1R and neuroprotection. All treatments, however, attenuated the activation of microglia via the CB2R activation, supporting the anti-inflammatory role of 2-AG in the retina.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsMicrogliaRatsAnimalsReceptors, CannabinoidRats, Sprague-Dawleyalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidRetinaReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Arachidonic AcidsGlycerides

Stichwörter der Autor:innen

2-arachidonoylglycerolABHD6CB1 and CB2 cannabinoid receptorsMAGLeye dropsmicroglianeuroinflammationneuroprotection

Substanzen

EndocannabinoidsReceptors, Cannabinoidalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2glyceryl 2-arachidonateArachidonic AcidsGlycerides

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
  • Department of Chemistry, University of Crete, Heraklion, 71003 Crete, Greece.
  • Center for Drug Discovery and Departments of Chemistry and Chemical Biology and Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.

ORCID-Profile: Dimitris Spyridakos, Nikos Chaniotakis

Förderung

  • NIDA NIH HHS
  • Hellenic Foundation for Research and Innovation/General Secretariat for Research and Technology
  • Special Account for Research, University of Crete
  • State Scholarship Foundation (IKY)

Zitieren

APA

Papadogkonaki, S., Spyridakos, D., Lapokonstantaki, E., Chaniotakis, N., Makriyannis, A., Malamas, M. S., & Thermos, K. (2023). Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115689

Vancouver

Papadogkonaki S, Spyridakos D, Lapokonstantaki E, Chaniotakis N, Makriyannis A, Malamas MS, et al. Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115689

BibTeX
@article{Papadogkonaki2023,
  author = {Papadogkonaki, Sofia and Spyridakos, Dimitris and Lapokonstantaki, Emmanouela and Chaniotakis, Nikos and Makriyannis, Alexandros and Malamas, Michael S and Thermos, Kyriaki},
  title = {Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115689}
}
Kostenlos starten →